John L. Leguyader

Array ( [id] => 3760007 [patent_doc_number] => 05741706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Anti-HIV ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/719593 [patent_app_country] => US [patent_app_date] => 1996-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 12543 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741706.pdf [firstpage_image] =>[orig_patent_app_number] => 719593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3856762 [patent_doc_number] => RE035749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Constructs of glyceraldehyde-3-phosphate dehydrogenase promoter and methods for expressing genes using said constructs' [patent_app_type] => 2 [patent_app_number] => 8/710744 [patent_app_country] => US [patent_app_date] => 1996-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10724 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/035/RE035749.pdf [firstpage_image] =>[orig_patent_app_number] => 710744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775690 [patent_doc_number] => 05808037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Oligomers which inhibit expression of collagen genes' [patent_app_type] => 1 [patent_app_number] => 8/712357 [patent_app_country] => US [patent_app_date] => 1996-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 11929 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808037.pdf [firstpage_image] =>[orig_patent_app_number] => 712357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038411 [patent_doc_number] => 05856462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Oligonucleotides having modified CpG dinucleosides' [patent_app_type] => 1 [patent_app_number] => 8/711568 [patent_app_country] => US [patent_app_date] => 1996-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4114 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856462.pdf [firstpage_image] =>[orig_patent_app_number] => 711568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774961 [patent_doc_number] => 05850018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Expression control sequence for general and effective expression of genes in plants' [patent_app_type] => 1 [patent_app_number] => 8/686417 [patent_app_country] => US [patent_app_date] => 1996-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5450 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/850/05850018.pdf [firstpage_image] =>[orig_patent_app_number] => 686417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4144044 [patent_doc_number] => 06063566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Catalytic RNA molecules' [patent_app_type] => 1 [patent_app_number] => 8/682423 [patent_app_country] => US [patent_app_date] => 1996-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 64726 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063566.pdf [firstpage_image] =>[orig_patent_app_number] => 682423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008279 [patent_doc_number] => 05859343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Recombinant sweet protein mabinlin' [patent_app_type] => 1 [patent_app_number] => 8/670186 [patent_app_country] => US [patent_app_date] => 1996-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8671 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859343.pdf [firstpage_image] =>[orig_patent_app_number] => 670186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044533 [patent_doc_number] => 05869246 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Triplex Oligonucleotides targeted to p120' [patent_app_type] => 1 [patent_app_number] => 8/666420 [patent_app_country] => US [patent_app_date] => 1996-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3412 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869246.pdf [firstpage_image] =>[orig_patent_app_number] => 666420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857524 [patent_doc_number] => 05792613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Method for obtaining RNA aptamers based on shape selection' [patent_app_type] => 1 [patent_app_number] => 8/662335 [patent_app_country] => US [patent_app_date] => 1996-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8385 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792613.pdf [firstpage_image] =>[orig_patent_app_number] => 662335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3906615 [patent_doc_number] => 05898031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-27 [patent_title] => 'Oligoribonucleotides for cleaving RNA' [patent_app_type] => 1 [patent_app_number] => 8/659440 [patent_app_country] => US [patent_app_date] => 1996-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 27519 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/898/05898031.pdf [firstpage_image] =>[orig_patent_app_number] => 659440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685530 [patent_doc_number] => 05695938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Anti-HIV ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/654773 [patent_app_country] => US [patent_app_date] => 1996-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4752 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695938.pdf [firstpage_image] =>[orig_patent_app_number] => 654773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3840948 [patent_doc_number] => 05707866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'DNA oligomers for inhibition of HIV by decreasing ribosomal frameshifting' [patent_app_type] => 1 [patent_app_number] => 8/651835 [patent_app_country] => US [patent_app_date] => 1996-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5860 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707866.pdf [firstpage_image] =>[orig_patent_app_number] => 651835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646661 [patent_doc_number] => 05683900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Pasteurella haemolytica PhaI restriction endonuclcape and methyltranstesase' [patent_app_type] => 1 [patent_app_number] => 8/643300 [patent_app_country] => US [patent_app_date] => 1996-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 9809 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683900.pdf [firstpage_image] =>[orig_patent_app_number] => 643300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733323 [patent_doc_number] => 05693777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'DNA encoding pasteurella haemolytica PhaI restriction endonuclease and methyltransterase' [patent_app_type] => 1 [patent_app_number] => 8/643297 [patent_app_country] => US [patent_app_date] => 1996-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 9815 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693777.pdf [firstpage_image] =>[orig_patent_app_number] => 643297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827922 [patent_doc_number] => 05760012 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Methods and compounds for curing diseases caused by mutations' [patent_app_type] => 1 [patent_app_number] => 8/640517 [patent_app_country] => US [patent_app_date] => 1996-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15861 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760012.pdf [firstpage_image] =>[orig_patent_app_number] => 640517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3721992 [patent_doc_number] => 05672477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Streptococcus lactis plasmid encoding for mucoidness' [patent_app_type] => 1 [patent_app_number] => 8/632642 [patent_app_country] => US [patent_app_date] => 1996-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4186 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672477.pdf [firstpage_image] =>[orig_patent_app_number] => 632642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741962 [patent_doc_number] => 05801031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Human and rat gamma glutamyl hydrolase genes' [patent_app_type] => 1 [patent_app_number] => 8/628291 [patent_app_country] => US [patent_app_date] => 1996-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12705 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801031.pdf [firstpage_image] =>[orig_patent_app_number] => 628291 [rel_patent_id] =>[rel_patent_doc_number] =>)